Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park
J Urol Oncol. 2024;22(1):59-67.   Published online 2024 Mar 31     DOI:
Citations to this article as recorded by Crossref logo
JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary
Cheol Kwak
Journal of Urologic Oncology.2024; 22(1): 1.     CrossRef